Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2-year CONDUCT study
Crossref DOI link: https://doi.org/10.1007/s00345-016-1884-5
Published Online: 2016-06-22
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Roehrborn, Claus G.
Oyarzabal Perez, Igor
Roos, Erik P. M.
Calomfirescu, Nicolae
Brotherton, Betsy
Palacios, Juan Manuel
Vasylyev, Averyan
Manyak, Michael J.
License valid from 2016-06-22